[HTML][HTML] Incidence of venous thromboembolism in hospitalized coronavirus disease 2019 patients: a systematic review and meta-analysis

C Zhang, L Shen, KJ Le, MM Pan, LC Kong… - Frontiers in …, 2020 - frontiersin.org
Background: Emerging evidence shows that coronavirus disease 2019 (COVID-19) is
commonly complicated by coagulopathy, and venous thromboembolism (VTE) is considered …

[HTML][HTML] Coagulopathy in COVID-19 and its implication for safe and efficacious thromboprophylaxis

F Langer, S Kluge, R Klamroth… - Hämostaseologie, 2020 - thieme-connect.com
The novel coronavirus, SARS-CoV-2, is causing a global pandemic of life-threatening
multiorgan disease, called COVID-19. Accumulating evidence indicates that patients with …

[HTML][HTML] Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment

A Gąsecka, JA Borovac, RA Guerreiro… - … drugs and therapy, 2021 - Springer
Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …

Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies

G Agarwal, A Hajra, S Chakraborty… - Therapeutic …, 2022 - journals.sagepub.com
Introduction: Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection resulting in COVID-19 disease is associated with widespread inflammation and a …

Venous thromboembolism in the era of COVID-19

KG Kyriakoulis, DG Kokkinidis, IA Kyprianou… - …, 2021 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) does not only affect the respiratory system but
appears to be a systemic disease. Venous thromboembolism is a common manifestation in …

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

B Bikdeli, MV Madhavan, D Jimenez, T Chuich… - Journal of the American …, 2020 - jacc.org
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

Incidence of venous and arterial thromboembolic complications in COVID-19: a systematic review and meta-analysis

SK Kunutsor, JA Laukkanen - Thrombosis research, 2020 - thrombosisresearch.com
Arterial thrombotic disease (atherosclerotic cardiovascular disease, CVD) and venous
thromboembolism (VTE)(comprising of deep vein thrombosis (DVT) and pulmonary …

Incidence of venous thromboembolism in hospitalized patients with COVID‐19

S Middeldorp, M Coppens… - … of Thrombosis and …, 2020 - Wiley Online Library
Abstract Background Coronavirus disease 2019 (COVID‐19) can lead to systemic
coagulation activation and thrombotic complications. Objectives To investigate the incidence …

Venous thromboembolism complicated with COVID-19: what do we know so far?

S Tal, G Spectre, R Kornowski, L Perl - Acta haematologica, 2020 - karger.com
Abstract Coronavirus disease (COVID-19) is caused by the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and is responsible for the ongoing 2019–2020 …

[HTML][HTML] Management of thrombotic complications in COVID-19: an update

A Hajra, SV Mathai, S Ball, D Bandyopadhyay… - Drugs, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …